Leuprolide Mesylate Patent Expiration
Leuprolide Mesylate was first introduced by Accord Biopharma Inc
Leuprolide Mesylate Patents
Given below is the list of patents protecting Leuprolide Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Camcevi Kit | US11717555 | Pharmaceutical compositions having a selected release duration | Jan 01, 2039 | Accord |
| Camcevi Kit | US12133878 | Pharmaceutical compositions having a selected release duration | Dec 18, 2037 | Accord |
| Camcevi Kit | US10646572 | Pharmaceutical compositions with enhanced stability | Jan 16, 2027 | Accord |
| Camcevi Kit | US9572857 | Pharmaceutical compositions with enhanced stability | Jan 16, 2027 | Accord |
| Camcevi Kit | US9744207 | Pharmaceutical compositions with enhanced stability | Jan 16, 2027 | Accord |
Leuprolide Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List